BrightSpring Health Services, Inc. has gained about 79.4% so far this year, significantly outperforming the Medical sector's average return of negative 4.9%. The company currently holds a Zacks Rank of 1, or Strong Buy, and its full-year earnings consensus estimate has risen 10.8% over the past 90 days. Within the Medical Services industry, which has lost an average of 7.7% year-to-date, BrightSpring's performance stands out. Another medical stock, Bioventus, has returned 18.2% this year and carries a Zacks Rank of 2, or Buy, with its current-year EPS estimate up 0.6% over three months.
BrightSpring Health Services, Inc. Common StockArticle highlights strong year-to-date performance, Zacks Strong Buy rating, and upward earnings estimate revision.
Bioventus IncMentioned as another medical stock with positive year-to-date return and a Zacks Buy rating, but only as comparison.